Which hedge funds own EWTX? EDGEWISE THERAPEUTICS INC, Q2 2026 13F holders
51 tracked hedge funds disclosed a position in EWTX (EDGEWISE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $2.4bn in total. The largest holder by portfolio weight is Orbimed Advisors LLC at 11.9% of its book. 14 opened a new position this quarter: Tyro Capital Management LLC, Diadema Partners LP, Gsa Capital Partners LLP, Boothbay Fund Management, LLC. 14 exited: Stempoint Capital LP, Ishara Investments LP, Sio Capital Management, LLC.
- 51
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 14
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 14
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $69.9m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $54.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $2.4bn
- Combined value Sum of the holders' reported positions in the security.
- 4.1%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Stempoint Capital LP | 1.8% | $9.2m |
| Ishara Investments LP | 1.6% | $1.5m |
| Sio Capital Management, LLC | 1.2% | $8.5m |
| Silverarc Capital Management, LLC | 0.2% | $1.3m |
| Seven Fleet Capital Management LP | 0.1% | $369k |
| Elmind Capital, LP | 0.09% | $315k |
| Cygnus Capital Advisors, LLC | 0.07% | $108k |
| Candriam S.C.A. | 0.07% | $14.1m |
| Caption Management, LLC | 0.06% | $1.2m |
| Freestone Grove Partners LP | 0.03% | $4.7m |
| Atom Investors LP | 0.02% | $313k |
| Jain Global LLC | 0.02% | $1.5m |
| Millennium Management LLC | 0.01% | $10.8m |
| Hudson Bay Capital Management LP | 0.0% | $407k |
Ownership over time
Who discovered EWTX first? Beta
The run: Q3 2023 → Q4 2024, +366%
| Frazier Life Sciences Management, L.P. | Q4 2023 | 0.3% | +2.8 pts |
| Parkman Healthcare Partners LLC | Q4 2023 | 0.5% | +2.2 pts |
| Cormorant Asset Management, LP high conviction | Q4 2023 | 1.0% | +2.2 pts |
| DAFNA Capital Management LLC | Q4 2023 | 0.9% | +2.1 pts |
| EcoR1 Capital, LLC | Q3 2022 | 0.7% | +0.1 pts |
| Deep Track Capital, LP | Q3 2022 | 0.6% | −0.1 pts |
| Logos Global Management LP | Q4 2023 | – | −2.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.